State Of Wyoming Ironwood Pharmaceuticals Inc Transaction History

State Of Wyoming

$587 Million
Q1 2024

A detailed history of State Of Wyoming transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, State Of Wyoming holds 35,995 shares of IRWD stock, worth $223,888. This represents 0.05% of its overall portfolio holdings.

Number of Shares

35,995

Previous 11,403 215.66%

Holding current value

$223,888

Previous $130,000 140.77%

% of portfolio

0.05%

Previous 0.02%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$8.32 - $15.45 $204,605 - $379,946	24,592 Added 215.66%	35,995 $313,000
Q4 2023 Feb 14, 2024	SELL	$8.79 - $11.51 $74,424 - $97,455	-8,467 Reduced 42.61%	11,403 $130,000
Q3 2023 Nov 14, 2023	SELL	$8.25 - $11.35 $68,887 - $94,772	-8,350 Reduced 29.59%	19,870 $191,000
Q2 2023 Aug 14, 2023	BUY	$10.1 - $11.6 $14,847 - $17,052	1,470 Added 5.5%	28,220 $300,000
Q1 2023 May 12, 2023	BUY	$10.37 - $12.56 $2,623 - $3,177	253 Added 0.95%	26,750 $281,000

Q4 2022 Feb 14, 2023	BUY	$9.9 - $12.43 $30,789 - $38,657	3,110 Added 13.3%	26,497 $328,000
Q3 2022 Nov 14, 2022	BUY	$10.14 - $12.38 $40,336 - $49,247	3,978 Added 20.5%	23,387 $242,000
Q2 2022 Aug 15, 2022	BUY	$11.05 - $12.72 $54,200 - $62,391	4,905 Added 33.82%	19,409 $224,000
Q1 2022 May 13, 2022	BUY	$10.61 - $12.88 $10,620 - $12,892	1,001 Added 7.41%	14,504 $182,000
Q4 2021 Feb 11, 2022	BUY	$10.86 - $13.95 $118,580 - $152,320	10,919 Added 422.56%	13,503 $158,000
Q3 2021 Feb 11, 2022	SELL	$11.92 - $13.92 $32,565 - $38,029	-2,732 Reduced 51.39%	2,584 $34,000
Q2 2021 Feb 11, 2022	BUY	$10.16 - $13.11 $34,940 - $45,085	3,439 Added 183.22%	5,316 $68,000
Q1 2021 Feb 08, 2022	BUY	$9.04 - $11.86 $16,968 - $22,261	1,877 New	1,877 $21,000

Others Institutions Holding IRWD

# of Institutions

296

Shares Held

170M

Call Options Held

27.1M

Put Options Held

2.28M

View Full List

About IRONWOOD PHARMACEUTICALS INC

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $953M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

More about IRWD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wyoming with notifications on news.

Account